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1. Introduction 
It is well-known that the incidence of lung malignancies increases. The increase of primary 
lung cancer is especially alarming. But the lung is also a target organ for other secondary 
malignancies, such as metastases of different origins. For the primary lung cancer, the 
therapy of choice is its radical resection (together with systematic lymphadenectomy). For 
pulmonary metastases, less radical resections are necessary. Both could be challenging for 
thoracic surgeons in case of limited lung function and in the case of multiple bilateral lung 
nodules – metastases. Furthermore, the newly detected lung tumor is in most cases 
diagnosed in elderly, active smokers with a limited lung function and significant 
comorbidity. Therefore, the above-mentioned planned radical resection in these “limited” 
patients is not possible. Thoracic surgeons face apparently a dead-lock situation having to 
operate radically and sparing enough functional lung parenchyma at the same time.  
This paper is dedicated to the topic of lung parenchyma sparing resection. It’s first part 
describes a laser resection of multiple lung lesions – metastases. The laser segmental lung 
resection and the sleeve bronchoplastic (angioplastic) resection are introduced in it’s second 
and third part, respectively. 
2. Laser resection for lung metastases 
2.1 History 
Already in 1786, John Hunter reported the first case report in history of pulmonary 
metastases. The primary cancer was a malignant tumor of the femur and the patient died of 
widespread pulmonary metastazing only 7 weeks after the leg was amputated (Allen et al., 
1993; Van Schil et al. 2008). In 1927, the first surgeon who performed a lung resection of 
pulmonary metastasis was Jan Divis from Prague (Divis, 1927). Barney and Churchill could 
note the real success after the surgery, removing a lung metastasis by a lobectomy. The 
renal-cell carcinoma was removed by nephrectomy, subsequently. The patient survived for 
over 20 years without any signs of recurrence (Barney & Churchill, 1939). 
Finally, a retrospective analysis of 205 patients after resection of pulmonary metastases 
should be mentioned. This report was published by Thomford in 1965 with a 5 Years-
Survival-Rate (Y-S) of 30.3% (Thomford 1965). 
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2.2 Introducing the laser in thoracic surgery 
In 1985, after establishing a 1064 nm Nd:YAG laser for standard endobronchial interventions 
(Häusinger et al, 1984), LoCicero reopened the debate on the use of lasers in open thoracic 
surgery as well (LoCicero, 1985, 1989). However, since his CO2 laser was a pure absorption 
or cutting laser, it proved inadequate for lung surgery and thus could not establish itself in 
this medical discipline. As a result, a number of medical centers in the United States, Japan 
and Europe began experimenting with 1064 nm Nd:YAG lasers, using bare fibers and 
sapphire tips to perform superficial resections (Branscheid, 1992; Kodama 1991, 1992; Lo 
Cicero 1985, 1989; Mineo, 1998; Moghissi, 1988; Rolle, 1988). As it follows, all of these teams 
achieved only low patient-loads and published no further results, mainly because the 
technical difficulties posed by the available 1064 nm lasers could not be overcome without 
further basic research. Table 1. 
The new era began by introducing the 1318 nm wavelength Nd:YAG laser system of  40 W 
power output. This high performance Nd: YAG laser system consisted of the thin flexible 
quartz fibres (400 μm) with low water content and of a four lens focusing handpiece. This 
new laser system was exclusively used in all patients undergoing a lung parenchyma 
sparing resection in our study. The next Section presents the description of this laser system. 
 
Author Article Laser 
Wave 
Length (nm) 
Laser Application 
LoCicero   1985 
Ann Thorac Surg  
CO2    Hemostasis,  
Sealing of Air Leaks 
Rolle 1988 
Laser in Med and Surg  
Nd:YAG 1064/1318 Experimental/clinical 
n=47 Wedge and 
Segmental Resections 
Moghissi 1988 
J Thoracic Cardiovasc Surg  
Nd:YAG 1064 Local Excision,  
“Coin Lesions” 
LoCicero 1989 
J Thoracic Cardiovasc Surg  
Nd:YAG 1064 Laser assisted pulmonary 
resections 
Kodama       1991 
J Thoracic Cardiovasc Surg  
Nd:YAG   1064  Resection of Lung 
Metastases n=25 
Branscheid  1992 
Eur J Cardiothorac Surg  
Nd:YAG   1064                Resection of Lung 
Metastases  
n=14 Laser only 
n=51 comb. with with 
Lobectomy 
Kodama       1992 
Kyobu Geka  
Nd:YAG   1064             Resection of Lung 
Metastases n=25 
Segmental Resection 
(NSCLC) n=25 
Mineo 1988 
Chest  
Nd:YAG   1064   Resection of Lung 
Metastases n=23 
Rolle 2006  
J Thorac Cardiovasc Surg  
Nd:YAG 1318 Lobe-Sparing Resection 
of Multiple Pulmonary 
Metastases n=328 
Table 1. Literature Survey: Nd:YAG/CO2 Laser resection in thoracic surgery. 
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2.2.1 Scientific background, description of 1318 Nd:YAG Laser 
Due to its parenchymal tissue having a typical water content of 80% but a very low tissue 
density (just a fifth of the liver parenchyma), a very low heat capacity and a variable air 
content, the lung is an ideal organ for phototermal laser applications. Therefore, resecting 
lung parenchyma requires a laser with a powerful coagulation capability in addition to 
excellent cutting properties, given the high vessel density. After all, the surgeon must 
always expect fistulae and increasing bronchopulmonary leaks, particularly when dissecting 
lung parenchyma, the more so the deeper one works down in central direction. The 
absorption behavior of different lasers in water differs a lot (Bayly, 1963; Bramson, 1968; 
Dinstl, 1981).  
The 1318 nm wavelength Nd:YAG laser significantly differs from the standard (1064 nm) 
wavelength by its ten times higher absorption in water but still offers sufficient laser light 
scatter, due its proximity to the beginning infrared spectrum, to satisfy the vital coagulation 
requirement as well. In fact the 1318 nm wavelength provided the intended combination 
effect - cutting capability plus coagulation capability - so perfectly as it could not be 
achieved with the 1064 nm wavelength (Rolle, 1988, 1989). As a welcome side-effect, we also 
found strong lung tissue shrinkage, which provides two additional advantages: mechanical 
reinforcement of the coagulation effect, and fistula sealing far into the central lobe region. In 
fact, the surfaces coagulated and sealed off through defocused irradiation with the 1318 nm 
laser withstand artificial ventilation pressures of up to 25 cm H20.  
As for the founding and developing of the above mentioned laser system, the name of 
Professor Axel Rolle has to be mentioned in this place (Rolle, 1988, 1989, 1999). 
The following design features were incorporated to develop a 1318 nm commercial design 
Trumph (formerly Hüttinger Medizintechnik, Umkirch, Germany) and Martin companies. 
The second wavelength is first generated by adapted reflection of the laser mirrors. High 
beam quality allows coupling into thin (less than 0.6 mm) optical quartz fibers with 
minimum losses. For flexible transmission to the area of application, special water-free 
quartz fibers are required as laser light absorption in water is 10 times higher at the 1318-nm 
wavelength (Bayly, et al., 1963; Stokes et al., 1981).  
A four-lens focusing handpiece was developed to concentrate the laser light and allow man-
ual manipulation of the beam onto lung tissue to keep the working-point focus in the tissue 
at 4 mm while avoiding heat generation in the focusing handpiece. The extremely high laser 
power density of 24kW/cm2 allows fast and precise cutting with simultaneous coagulation 
and sealing of lung tissue. A high performance smoke evacuation system eliminates the 
vaporization fumes, which are unavoidable during parenchyma dissection with this laser 
(Fig.1). 
2.3 Surgical technique 
Laser metastasectomy is performed via an anterolateral thoracotomy (staged 3 to 4 weeks, if 
bilateral) after fulfilling the standard indication criteria for pulmonary metastasectomy 
(histologically confirmed primary tumor after its radical resection or its fully controlled 
stage). Preoperative evaluations are the same as a for routine thoracic intervention; 
including a history and physical examination, chest computed tomography (CT), pulmonary 
function tests, and a bone scan. If the signs or symptoms are suggestive, a head CT is also 
obtained. Patients with identified extrapulmonary metastases are excluded from surgery.  
The technique, indication and possibility to save lobes are demonstrated on a case report. A 
59-years-old female patient with a history of radically resected colorectal carcinoma  
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Fig. 1. Components of modern Laser equipment for the application on lung tissue (1318 nm 
wavelength, 40 W power output, beam quality, energy efficiency, high performance smoke 
evacuation system, 0.4 mm diameter of fibre, focusing handpiece, flexible quartz fibres /low 
water content/). 
(Adenocarcinoma of rectosigmoid pT4 pN1 pM1 (Liver), G3, Status post hemihepatectomy, 
chemotherapy and radiation) was referred to our Institute. A significant progress of 
(isolated) lung metastases was reported. The chest CT demonstrates the situation after the 
successful laser resection of pulmonary metastases on the right side and just before the 
procedure on left (Fig. 2).  
 
 
Fig. 2. Case Report 1: The Chest CT demonstrates the situation after the successful laser 
resection of pulmonary metastases on the right side and just before the procedure on left. 
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The new 1318 nm Nd:YAG laser system offers a unique opportunity to perform the 
procedure in a  parenchyma-saving and lobe-sparing way. Therefore, the bilateral laser 
procedure was performed. The intraoperative situation can be seen on the series of 
photographs: the pulmonary artery is mobilized on a vessel loop; the upper vein lies next to 
the central, 30 mm great metastasis (Fig. 3). The laser resection of this metastasis was than 
performed. The next figure (Fig. 4) shows the situation immediately after the laser resection. 
The intraoperative situation – its close relation to segmental pulmonary vein - can be easily 
recognized. Exposed bronchial branches and segmental vessels at the segmental level were 
over-sewn and ligated with absorbable suture (4-0/ 3-0). The lung architecture and 
orientation was reconstructed following each nodular resection by reapproximating the 
visceral pleura with a running absorbable suture (4-0 Vicryl) (Fig. 5). This technique avoided 
a distortion of the lung tissue to allow consistent orientation and palpation of the initially 
noted lung nodules. At the end of the procedure, the resected lung was re-insuflated by a 
standard way in accordance with the routine thoracic surgical practice. 
By performing the metastasectomy the above-described way, it was possible to save the 
patient’s lobes and to operate on both lungs by a laser parenchyma sparing manner. The 
patient, now one year after the procedure, is in good condition with a full physical activity, 
living free of metastases. 
 
 
 
 
Fig. 3. Intraoperative view: Laser resection of 30 mm central metastasis localized in left 
upper lobe centrally to pulmonary artery. Intraoperative situation: pulmonary artery and 
the upper vein are mobilized on vessel loop (blue). 
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Fig. 4. The intraoperative situation – its close relation to segmental pulmonary vein - can be 
easily recognized. Exposed bronchial branches and segmental vessels at the segmental level 
were over-sewn and ligated with absorbable suture (4-0/ 3-0). 
 
 
 
Fig. 5. Intraoperative view: Reconfiguration of the left upper lobe with continuous suture of 
the pleura visceralis. 
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2.4 Results 
From January 1996 to May 2004, lung laser resections were performed in 328 patients. There 
were 164 males and 164 females and the main indications for laser lung resections included 
lung metastases of the following primaries: renal carcinoma in 112 cases, colorectal in 91 and 
breast cancer in 35 cases. In the remaining 90 cases laser resection was performed for 
metastases of lung cancer (n=12), malignant melanoma (n=1), sarcomas (n=15), head and 
neck carcinoma (n=12) and for metastases of other less frequent ones (n=27). These results 
were already reported and published elsewhere (Rolle et al., 2006). 
This retrospective study analyzes the second largest indication group of colorectal 
carcinoma lung metastases (Pereszlenyi et al., 2006a, 2006b). 46 females and 45 males with 
median age of 64 yrs, ranged from 43 to 80 years were included. The number of complete 
removed metastases was 629, ranged 1-56; median 7 per patient. All laser resections were 
performed by the Nd:YAG laser system of 1318 nm wavelength with its lung parenchyma 
saving effect. The complete resection (R0) was achieved in 78 patients, incomplete (R1/2) in 
13 patients. 
There was no perioperative mortality. Follow-up was completed for all patients and ranged 
from 1-30 Mo with a median of 20 months. 1 Year-Survival (Y-S) for complete (R0) resection 
was 82%, 2 Y-S was 68%, 3 Y-S 42% and 5 Y-S was 22% (Fig. 6).  For incomplete (R1/2) 
resection (n=13):  1 Year-Survival was 85%, 2 Y-S was 54%, 3 Y-S 46%, 4 Y-S 9% and 5 Y-S 
was 0 (Fig. 6).  
Despite of that the 7 Metastases pro patient was removed and 19% of lymphatic-nodes 
involvement, the radical resection (R0) could be achieved. In 13 patients was the resection 
incomplete (R1/R2). For the R0 versus R1/2 see the Figure 6. The survival with and without 
lymphatic-node-involvement (N1-hilum, N2-mediastinum) after the radical resection (R0N0 
versus R0N1/2) is demonstrated in Figure 7. 
 
 
Fig. 6. Kaplan-Meier curve showing survival according to resection (Bullets = complete R0, 
squares = incomplete R1/R2 resections).  
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Fig. 7. Kaplan-Meier curve showing survival according to lymphnode-involvement (Bullets 
= complete without LN-involvement R0N0, squares = complete with LN1/N2-involvement 
R0 N1/N2).  
3. Laser segmental lung resection 
The technique of conventional lung segment resection, so called segmentectomy, is well 
known from the pioneer age of the thoracic surgery (pneumoftiseology) when the apical 
sublobar lung resections were performed for lung tuberculosis. Nowadays, those resections 
are not so widely spread due to their “not enough radicalism” for lung cancer cases.  
However, as it is already stated in the Introduction, these resections will gain more and 
more importance due to their lung parenchyma-sparing effect and the improving results on 
early postoperative morbidity and mortality (Keenan et al., 2004; Harada et al., 2005). 
In this place, it should be emphasized that the segmental resection is also an anatomical 
lung resection as the lobectomy. It respects the anatomical structure of the lung with its 
bronchial and vascular composites together with its lymphatic flows.  
A significant role in the technique of the segmental resection belongs to the laser system. Its 
cutting effect enables the thoracic surgeon to perform this kind of resection exactly within 
the anatomical boarders of the pulmonary segment. Therefore it is feasible also for segments 
where the “classical” segment resections can only hardly be obtained, e.g. segment III, IX, X etc.  
3.1 Surgical technique 
Laser segmentectomy is performed via an anterolateral muscle-sparing thoracotomy after 
fulfilling the standard indication criteria for a lung cancer resection (histologically 
confirmed lung tumor in its functional and oncologic operable stage). Preoperative 
evaluations are the same as for a routine thoracic intervention; including a history and 
physical examination, chest computed tomography (CT), pulmonary function tests, and a 
PET scan. If there are positive mediastinal lymphatic nodes proved by the test, a video-
mediastinoscopy in order to clarify the N2/N3 status is added prior to the resection.  
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Next, a case report presents the technique of laser segmental lung resection. A 66-years-old 
male patient with histological confirmed Adenocarcinoma of the right upper lobe was 
evaluated for a lung resection. Because of the patient’s significant comorbidity (ischemic 
heart disease, arterial hypertension, diabetes mellitus) and poor lung function (COPD, active 
smoker with history of 30 Pack/Years, FEV1 55%), the limited lung resection – Laser 
resection of the Segment 1 - was performed. 
For the patient’s preoperative images see Figure 8.  
 
 
Fig. 8. Chest CT and X-ray pictures of Case 2. The perioperative images are on the left and 
the postoperative images are on the right side.  
After the mobilization of the lung hilus, the segmental vessels and bronchus were mobilized 
on vessel loops. Fig.9. After this step, the lung parenchyma resection was performed by the 
laser system within the anatomical boarders of the Segment 1. Fig.10. The visceralisation 
(reapproximating the visceral pleura with a running absorbable suture /4-0 Vicryl/) in 
order to restore the architecture of the upper lobe followed. As it was already described 
above, this technique avoided a distortion of the lung tissue to allow consistent orientation 
and palpation of the lung parenchyma. At the end of the procedure, the resected lung was 
re-insuflated by a standard way in accordance with the routine thoracic surgical practice. 
Radical lymphadenectomy is routinely added to this procedure (Pereszlenyi et al., 2006).  
The patient is now 3 years after the procedure, without any signs of tumor recurrence. The 
histological examination of the resected specimen has proved an Adenocarcinoma of the 
lung 3 cm of diameter, radically (R0) removed via the laser resection of the Segment 1. For 
postoperative CT scans see Figure 8. 
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Fig. 9. Right lung hilus is mobilized; truncus anterior on the blue vessel loop with its 
segmental artery branches A1, A3. 
 
Fig. 10. Laser segmental resection within the anatomical boarders of the Segment 1. 
3.2 Results 
From January 1996 to December 2001, laser segmental lung resections were performed in 53 
patients (Pereszlenyi et al., 2006). The results after these resections were compared to 
standard lobectomies /n=154/ for non-small cell lung cancer (NSCLC). The data of this 
comparison are presented in the Table 2.  
As it follows, the 1, 3, 5 Year-Survival (Y-S) is comparable in both groups, there is no 
statistical significance /p=0.696/ in terms of tumor recurrence rate (26.4% versus 29.2%). 
The postoperative mortality rate (11.3%) after laser lung segmental resection is explained by 
the significant comorbidity, limited lung function in elderly patients in whom this kind of 
lung parenchyma sparing resection was performed. Tab.2. 
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To conclude, we are convinced that radical surgical resection is still the therapy of choice in 
NSCLC treatment. However, laser segmental lung resection represents an optimal treatment 
eventuality especially for those high risk patients in whom the standard resection – 
lobectomy is not feasible or performable.  
Our study demonstrates the possibility and justification of this treatment modality with 
comparable results after the standard ones (Harada et al., 2005).  
 
 n 
Mean Age/yrs 
(Range) 
Intraoperative 
mortality 
Postoperative 
mortality 
1,3,5  
Years 
Survival 
Tumor 
Recurrence 
Rate 
Laser 
Segmental 
Resection 
53 
67.5 
(49.5-82.7) 
0 11.3% 
95% 
82% 
65% 
26.4% 
Lobectomy 154 
62.5 
(28.3-77.6) 
0 1.9% 
92% 
71% 
58% 
29.2% 
Table 2. Laser segmental lung resection versus standard lobectomy for primary lung cancer 
(n=207). Selection criteria for laser segmental resection: high risk patients (elderly patient, 
poor performance status, FEV1<65%, significant comorbidity) and peripheral tumors of ≤ 
4cm diameter. 
4. Sleeve bronchoplastic lung resection 
Last but not least, the sleeve lobectomy should be mentioned. Centrally localized lung 
tumors can be resected by a lobectomy extended into a resection of central part of the 
invaded bronchus. The shape of such resected bronchus has a form of a sleeve. That’s where 
the term “sleeve” lobectomy originates.  There are numerous published studies showing the 
clear benefit for this type of lung resections. The most important advantage includes the 
avoidance of a major lung resection, e.g. pneumonectomy by performing a sleeve 
lobectomy. Its technique is well known, but in case of constructing so called “Neo-carina” 
followed by its re-implantation to the main stem bronchus can be very challenging also for 
experienced surgeons. Fig.11.  
 
Fig. 11. Sleeve middle and lower (bi-)lobectomy: Re-implantation the upper lobe bronchus 
into main-stem bronchus right (or into distal trachea with construction of the “neo-carina”) 
after resection the tumor within the bilobectomy. Scheme. 
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In case of multiple lung lesions, the laser system plays a significant role. The centrally 
located endobronchial tumor is removed by a sleeve lobectomy, and any smaller peripheral 
lesions (satellites) are resected by laser. Fig.12. The technique of the laser resection is 
presented in detail in the first part of this chapter. Fig. 13.  
 
 
Fig. 12. Case Report 3: Chest CT shows the central lung tumor in the right lower lobe and 
two small satellites in the periphery of the lung.  
 
Fig. 13. Scheme of laser resection of small peripheral nodule located in the middle lobe after 
sleeve lower lobe resection for a large central located endobronchial tumor. 
4.1 Surgical technique, patients and methods 
Between January 2005 and January 2011, 58 patients (42 males, 16 females, mean age 61 yrs 
range 24 – 83) underwent sleeve lobectomy (SL) in our Institute. The indications for SL were: 
non-small cell lung carcinoma (NSCLC) in 47 /Fig.14/, and pulmonary metastases in 11 
patients. Fig.15. As the metastatic pulmonary lesions were multiple, the Laser Resection (LR) 
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of these satellites was added to the SL procedure. The main indication for laser resection 
were metastases of renal-cell (n=4) and colorectal-carcinoma (n=3).  Fig.15. The most 
detected histologic type of NSCLC was squamous-cell carcinoma (n=22), followed by 
adenocarcinoma (n=14). The laser resection (combined by SL) was performed after fulfilling 
the standard criteria for metastasectomy: primary tumors were radically removed and there 
were no evidence of any distant extrathoracic metastases. In four NSCLC patients the 
arterial sleeve was added to the left upper bronchial SL. Lymphadenectomy was routinely 
added to the both parenchyma-saving procedures. 
The Tumor Stage is shown in the Figure 16 according to the newest, revised TNM 
Classification from 2009 (Goldstraw et al., 2007).  
 
 
Fig. 14. Tumor histology distribution (NSCLC; n=47). 
 
 
Fig. 15. Tumor histology distribution (Lung Metastases; n=11). 
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Fig. 16. Tumor Stage according to TNM Classification 2009 (n=47). yT0N0 - As the result of 
the successful neoadjuvant treatment, the tumor is not detectable in the resected lung 
specimen.   
The location of the tumors and types of sleeve resections are shown in Table 3. Almost 40% 
of the patients underwent right sleeve upper lobe resection. 
 
 
Side and Type of Procedure Number of Patients (%) 
Right Lung   
   Upper Lobe 23 (39) 
   Middle Lobe 1 (2) 
   Middle and Lower Lobe 1 (2) 
   Lower Lobe 14 (24) 
   
Left Lung  
   Upper Lobe 12 (21) 
   Lower Lobe 7 (12) 
Table 3. The location of tumors and types of sleeve resections (n=58). 
Following the double-lumen tube intubation and the standard anterolateral, muscle-sparing 
thoracotomy, we proceed with the resection. A bronchial anastomosis is performed by 
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interrupted monofilament absorbable suture of PDS 3-0 or 4-0. The vascular anastomosis 
was performed by running suture of the non-absorbable material of Prolene 5-0 (or 4-0) in 
four NSCLC patients after the left upper sleeve lobectomy was finished. 
Mediastinal (hilar) lymphadenectomy is routinely performed as well as an intraoperative 
frozen section analysis of the resected bronchus (and vessel). After the reconstruction of the 
bronchus, a routine fiber bronchoscopy is always performed by the first surgeon. In our 
series, we didn’t cover the bronchial anastomosis by any autologeous flap or any other 
materials.  
4.2 Results 
A negative bronchial (vascular) margin was achieved in all. No 30-days postoperative 
mortality occurred. Follow-up (completed for all patients with median of 12 Mo) showed no 
anastomotic complications, no local recurrence on the bronchial (arterial) anastomosis. 
Survival was analyzed according to Kaplan-Meier method with the estimated 1, 2, 4 years 
overall survival. Fig. 17. 
 
 
 
 
Fig. 17. Kaplan-Meier curve showing Survival at 20, 40, 60 Months. 
In accordance with the reported results from the literature we can also conclude, the 
bronchial and vascular sleeve lobectomy can be performed safely, and is a good alternative 
solution to avoid pneumonectomy (Konstantinou et al., 2009; Ludwig et al., 2005).  
As shown in our study, selected patients with central lung metastases can be also included 
for this procedure after fulfilling the standard criteria for pulmonary metastasectomy. The 
central role for these kinds of procedures belongs to the laser lung-parenchyma-saving 
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resection. In our study all laser resections were performed by a 1318-nm Nd:YAG laser 
system of 40 W power output.  
Laser resection may expand the scope of surgical treatment for pulmonary metastases, 
allowing a more complete resection. The indications for laser resection may expand to 
include patients who are not considered ideal candidates for lung metastasectomy because 
of poor residual lung function or multifocal pulmonary disease. The 1318-nm Nd:YAG laser 
for the resection of pulmonary metastases demonstrates a significant influence on the con-
servation of tissue during metastasectomy and appears to minimize complications. 
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